Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $47,379 - $63,325
540 Added 0.38%
142,979 $13.9 Million
Q4 2022

Feb 15, 2023

BUY
$80.93 - $108.63 $3.4 Million - $4.57 Million
42,039 Added 41.87%
142,439 $14.7 Million
Q3 2022

Nov 14, 2022

SELL
$82.16 - $96.94 $8.82 Million - $10.4 Million
-107,400 Reduced 51.68%
100,400 $8.51 Million
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $14.9 Million - $18 Million
207,800 New
207,800 $17.2 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Bridger Management, LLC Portfolio

Follow Bridger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.